Javed, A., & Reder, A. T. (2016). Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug. Neurol Neuroimmunol Neuroinflamm.
Chicago Style CitationJaved, Adil, i Anthony T. Reder. "Rising JCV-Ab Index During Natalizumab Therapy for MS: Inauspicious for a Highly Efficacious Drug." Neurol Neuroimmunol Neuroinflamm 2016.
Cita MLAJaved, Adil, i Anthony T. Reder. "Rising JCV-Ab Index During Natalizumab Therapy for MS: Inauspicious for a Highly Efficacious Drug." Neurol Neuroimmunol Neuroinflamm 2016.
Atenció: Aquestes cites poden no estar 100% correctes.